Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 41

Trial Status

Completed1

Role Distribution

Other Roles1

Activity Timeline

Clinical Trials (1)

NCT04674254Phase 4Completed
Macular Perfusion Changes After Anti-VEGF Versus Targeted Retinal Photocoagulation in Proliferative Diabetic Retinopathy
Diabetic RetinopathyProliferative Diabetic RetinopathyVascular Endothelial Growth Factor Overexpression
StudydirectorStart date: 2021-03-30

Research Network

Collaboration Network

9 collaborators·19 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Ahmed A Abdel-Kader, MD, PhD

Cairo University

Moderately Similar
3 trials

Shared therapeutic areas:

Diabetic RetinopathyVascular Endothelial Growth Factor OverexpressionProliferative Diabetic Retinopathy

Worked with same sponsors:

Cairo University
Collaborated on 1 trial
Similarity Score34%

Mohamed A Eldaly, MD, PhD

Cairo University

Moderately Similar
1 trials

Shared therapeutic areas:

Diabetic RetinopathyProliferative Diabetic RetinopathyVascular Endothelial Growth Factor Overexpression

Worked with same sponsors:

Cairo University
Collaborated on 1 trial
Similarity Score34%

Ahmed A Mohalhal, MD, PhD

Cairo University

Moderately Similar
2 trials

Shared therapeutic areas:

Diabetic RetinopathyVascular Endothelial Growth Factor OverexpressionProliferative Diabetic Retinopathy

Worked with same sponsors:

Cairo University
Collaborated on 1 trial
Similarity Score34%

Ayman G Elnahry, MD, PhD

Cairo University

Moderately Similar
3 trials

Shared therapeutic areas:

Diabetic RetinopathyVascular Endothelial Growth Factor OverexpressionProliferative Diabetic Retinopathy

Worked with same sponsors:

Cairo University
Collaborated on 1 trial
Similarity Score34%

Virgilio Lima Gomez, MD, MsC

Hospital Juarez de Mexico

Related
5 trials

Shared therapeutic areas:

Diabetic RetinopathyProliferative Diabetic Retinopathy
Similarity Score20%

Chung-May Yang, MD

National Taiwan University Hospital

Related
9 trials

Shared therapeutic areas:

Proliferative Diabetic RetinopathyDiabetic Retinopathy
Similarity Score20%

Dulce M Razo Blanco Hernandez, MD

Hospital Juarez de Mexico

Related
4 trials

Shared therapeutic areas:

Diabetic RetinopathyProliferative Diabetic Retinopathy
Similarity Score20%

Hugo Quiroz-Mercado, MD

Asociación para Evitar la Ceguera en México

Related
8 trials

Shared therapeutic areas:

Diabetic RetinopathyProliferative Diabetic Retinopathy
Similarity Score20%

Iwar Klimes, Prof., MD, DrSc.

Novartis Slovakia, s.r.o.

Related
1 trials

Shared therapeutic areas:

Diabetic Retinopathy
Similarity Score10%

Xiaorong Li, professor

Tianjin Medical University Eye Hospital

Related
5 trials

Shared therapeutic areas:

Diabetic Retinopathy
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT04674254Phase 4StudyDirector

Macular Perfusion Changes After Anti-VEGF Versus Targeted Retinal Photocoagulation in Proliferative Diabetic Retinopathy

Diabetic RetinopathyProliferative Diabetic RetinopathyVascular Endothelial Growth Factor Overexpression
Completed

All 1 trials loaded